Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000626226 | SCV000746872 | benign | Spinocerebellar ataxia type 21 | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002529783 | SCV003721160 | uncertain significance | Inborn genetic diseases | 2022-12-15 | criteria provided, single submitter | clinical testing | The c.343G>A (p.V115M) alteration is located in exon 3 (coding exon 3) of the TMEM240 gene. This alteration results from a G to A substitution at nucleotide position 343, causing the valine (V) at amino acid position 115 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |